Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of chronic diseases
3.2.1.2 Advances in diagnostic technologies
3.2.1.3 Increasing awareness of antioxidant therapies
3.2.1.4 Rising research in drug discovery and development
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of instruments
3.2.2.2 Stringent regulatory challenges
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.5.1 Core technologies
3.5.2 Adjacent technologies
3.6 Future market trends
3.7 Gap analysis
3.8 Porter’s analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Instruments
5.3 Consumables
5.3.1 Kits
5.3.2 Reagents
Chapter 6 Market Estimates and Forecast, By Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Indirect assays
6.2.1 Protein-based assays
6.2.2 Lipid-based assays
6.2.3 Nucleic acid-based assays
6.3 Antioxidant capacity assays
6.3.1 Glutathione assays
6.3.2 Ascorbic acid assays
6.3.3 Cell-based exogenous antioxidant assays
6.4 Enzyme-based assays
6.5 Reactive oxygen species-based assays
Chapter 7 Market Estimates and Forecast, By Technology, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Enzyme-linked immunosorbent assay (ELISA)
7.3 Flow cytometry
7.4 Chromatography
7.5 Microscopy
7.6 Other technologies
Chapter 8 Market Estimates and Forecast, By Disease Type, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Cardiovascular disease
8.3 Respiratory diseases
8.4 Cancer
8.5 Diabetes
8.6 Other diseases
Chapter 9 Market Estimates and Forecast, By End Use, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 Pharmaceutical and biotechnology industries
9.3 Academic research institutes
9.4 Contract research organizations (CROs)
9.5 Clinical laboratories
9.6 Other end users
Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Netherlands
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 UAE
Chapter 11 Company Profiles
11.1 AMSBIO
11.2 ABCAM
11.3 Agilent Technologies
11.4 Biorbyt
11.5 Cayman Chemical
11.6 Cell Biolabs
11.7 Dojindo Molecular Technologies
11.8 Enzo Biochem
11.9 GenScript Biotech Corporation
11.10 LifeSpan BioSciences
11.11 Merck
11.12 Promega Corporation
11.13 QIAGEN
11.14 RayBiotech
11.15 Thermo Fisher Scientific
